CSI Market
Sign In | Register

Cellectis S a (CLLS) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CLLS Annual Cash Flow →
The table below presents a historical view of Cellectis S a's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		0 0 0 (Dec 31 2024)
Operating Activities
Income-68.02
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Adjustments For Gain Loss On Disposals PropertyPlant And Equipment0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Interest Received Classified As Operating Activities8.43
Adjustments For Depreciation And Amortisation Expense-
Adjustments For Finance Income Cost-
Adjustments For Sharebased Payments-
Adjustments For Provisions-
Other Adjustments For Noncash Items-
Cash Flows From Used In Operations Before Changes In Working Capital-
Adjustments For Decrease Increase In Inventories-
Adjustments For Decrease Increase In Subsidies Receivables-
Adjustments For Increase Decrease In Trade Account Payable-
Adjustments For Increase Decrease In Deferred Income And Contract Liabilities-
Cash Flows From Used In Operating Activities Continuing Operations-
Cash Flows From Used In Operating Activities Discontinued Operations-
Income taxes0.00
Purchase Of Intangible Assets Classified As Investing Activities1.17
Accounts Receivable0.00
Adjustments For Decrease IncreaseIn Trade Account Receivable0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities5.12
Discontinued operations0.00
Net Cash flow from Operating Activities-39.40
Investing Activities
Capital Expenditures2.36
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Purchase Of Investments Other Than Investments Accounted For Using Equity Method0.00
Cash Flows From Net Change In Non Current Financial Assets-
Cash Flows From Losing Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities-
Cash Flows From Used In Investing Activities Continuing Operations-
Cash Flows From Used In Investing Activities Discontinued Operations-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net2.36
Discontinued operations0.00
Net Cash Flow from Investing Activities-29.48
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net68.89
Increase Decrease In Cash And Cash Equivalents-
Proceeds From Payments For Sale Or Issue Of Treasury Shares-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-16.76
Effect of exchange rate on cash flow3.93
Discontinued operations0.00
Free Cash Flow-37.04
Total Cash Flow143.25
4 historic quarters locked

Sign in to unlock the full Cellectis S a cash flow history.

Sign In Create Free Account

About Cellectis S A Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-116428

Figures are derived from filed reports and may be restated. Historical data is subject to revision.